SCHEMBL1633732

SCHEMBL1633732

CCc1[c]cccc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9359701 0.83 CNR1 (0.35)
SCHEMBL27561165 0.81 TRPA1 (0.38)
SCHEMBL6222946 0.79 TYR (0.39)
SCHEMBL28016932 0.79
SCHEMBL6868166 0.78 BID (0.41)
SCHEMBL27498294 0.77
SCHEMBL16719360 0.77 TP53 (0.34)
SCHEMBL16720626 0.77 KDM4E (0.39)
SCHEMBL5269201 0.77 BID (0.44)
SCHEMBL5269764 0.77 BID (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040799-A1 USE OF REYANNING IN PREPARATION OF DRUG FOR TREATING SARS-COV-2 ASYMPTOMATIC OR MILD INFECTION IN CHILDREN OR ADOLESCENTS 清华德人西安幸福制药有限公司 2024-02-29 WO claimed
CN-101394829-A Composition for the oxidative dyeing of keratin fibers and method for using such a composition PROCTER & GAMBLE (US) 2009-03-25 CN claimed
EP-0986560-B1 PYRROLO 2,1,5-CD]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES KAROBIO AB (SE) 2004-03-24 EP claimed
EP-1268568-A4 NO VOC RADIATION CURABLE RESIN COMPOSITIONS FOSTER MILLER INC (US) 2003-05-28 EP claimed
EP-1268568-A1 NO VOC RADIATION CURABLE RESIN COMPOSITIONS FOSTER MILLER, INC. (US) 2003-01-02 EP claimed
WO-2001060870-A1 NO VOC RADIATION CURABLE RESIN COMPOSITIONS FOSTER MILLER, INC. (US) 2001-08-23 WO claimed
EP-0830349-B1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS DU PONT PHARM CO (US) 2000-03-22 EP claimed
EP-0830349-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-25 EP claimed
WO-1996039393-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-12 WO claimed
WO-2023182327-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, ORGANIC EL DISPLAY DEVICE, AND METHOD FOR PRODUCING CURED PRODUCT 東レ株式会社 2023-09-28 WO disclosed
CN-115698854-A Photosensitive resin composition, cured product, display device, semiconductor device, and method for producing cured product 东丽株式会社 2023-02-03 CN disclosed
EP-2900645-B1 HERBICIDAL AND FUNGICIDAL 3-PHENYLISOXAZOLIN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-21 EP disclosed
CN-104235186-B Joint bearing lubricant system 波音公司 2019-05-31 CN disclosed
US-9856914-B2 Joint bearing lubricant system THE BOEING COMPANY (US) 2018-01-02 US disclosed
US-5086173-A Hydrogenating in presence of palladium catalyst without isolating the intermediates CIBA-GEIGY CORPORATION (US) 1992-02-04 US disclosed
EP-0457730-A2 Process for preparation of thioderivatives of alkylhydroxyanilinotriazine CIBA-GEIGY AG (CH) 1991-11-21 EP disclosed
US-5017703-A Antiallergens, antiinflammatory FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-05-21 US disclosed
US-4935432-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-06-19 US disclosed
EP-0324431-A1 New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-07-19 EP disclosed
US-4734504-A 1-alkylated diazolidinones ELI LILLY AND COMPANY (US) 1988-03-29 US disclosed